Publication Date | SPC No. | SPC Category | Details Rows may repeat to show multiple inventors or applicants depending on "Sort By" |
---|
27 May 2015
(Journal 6575)
| SPC/GB02/001 | Entered Into Force | Applicant: Aventis Pharma S.A. 20 Avenue Raymond Aron, F-92160, Antony, France
Product: Telithromycin and addition salts thereof with pharmaceutically acceptable acids
Product Type: Medicinal Authorised: UK EU/1/01/191/001-004 10 July 2001
Authorised Extension:
Patent No: EP0680967 Title: Erythromycin derivatives, their process of preparation and their uses as medicaments
SPC No: SPC/GB02/001 Date entered into force: 2 May 2015 Effective Period Expires On: 9 July 2016 |
27 May 2015
(Journal 6575)
| SPC/GB06/009 | Entered Into Force | Applicant: Pharmacia & Upjohn Company LLC Kalamazoo, Michigan 49001, USA
Product: [R-(R*,R*)]-N-[3-[1-[5,6-dihydro-4-hydroxy-2-oxo-6-(2-phenylethyl)-6-propyl-2H-pyran-3-yl]propyl]phenyl]-5-(trifluoromethyl)-2-pyridinesulfonamide or a pharmaceutical salt thereof = (Tipranavir or a pharmaceutical salt thereof)
Product Type: Medicinal Authorised: CH 57330 25 August 2005 UK EU/1/05/315/001 25 October 2005
Authorised Extension:
Patent No: EP0758327 Title: Pyranone compounds useful to treat retroviral infections
SPC No: SPC/GB06/009 Date entered into force: 4 May 2015 Effective Period Expires On: 3 May 2020 |
27 May 2015
(Journal 6575)
| SPC/GB10/015 | Entered Into Force | Applicant: Alexion Pharmaceuticals, Inc Cheshire, CT06410, USA
Product: Eculizumab
Product Type: Medicinal Authorised: UK EU/1/07/393/001 20 June 2007
Authorised Extension:
Patent No: EP0758904 Title: Methods and compositions for the treatment of glomerulonephritis
SPC No: SPC/GB10/015 Date entered into force: 1 May 2015 Effective Period Expires On: 30 April 2020 |
27 May 2015
(Journal 6575)
| SPC/GB15/026 | Lodged | Applicant: Nektar Therapeutics 455 Mission Bay, Boulevard South, Suite 100, San Francisco, CA 94158 USA
Product: MOVENTIG which is the oxylate salt of the alpha-epimer of naloxegol
Product Type: Medicinal Authorised: UK EU/1/14/962 8 December 2014
Authorised Extension:
Patent No: EP1694363 Title: Monodisperse PEGylated naloxol compositions
SPC No: SPC/GB15/026 Date Lodged: 28 April 2015 |